These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18249134)

  • 1. Investigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout mice.
    Christoph T; Bahrenberg G; De Vry J; Englberger W; Erdmann VA; Frech M; Kögel B; Röhl T; Schiene K; Schröder W; Seibler J; Kurreck J
    Mol Cell Neurosci; 2008 Mar; 37(3):579-89. PubMed ID: 18249134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR; Pan HL
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.
    Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M
    Circ Res; 2007 Apr; 100(7):1063-70. PubMed ID: 17347480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons.
    Niiyama Y; Kawamata T; Yamamoto J; Omote K; Namiki A
    Neuroscience; 2007 Aug; 148(2):560-72. PubMed ID: 17656027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats.
    Kanai Y; Nakazato E; Fujiuchi A; Hara T; Imai A
    Neuropharmacology; 2005 Dec; 49(7):977-84. PubMed ID: 15998524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
    Sándor K; Helyes Z; Elekes K; Szolcsányi J
    Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro.
    Shimizu I; Iida T; Horiuchi N; Caterina MJ
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1378-85. PubMed ID: 15947039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo.
    Christoph T; Grünweller A; Mika J; Schäfer MK; Wade EJ; Weihe E; Erdmann VA; Frank R; Gillen C; Kurreck J
    Biochem Biophys Res Commun; 2006 Nov; 350(1):238-43. PubMed ID: 16996476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat and mechanical hyperalgesia in mice model of cancer pain.
    Asai H; Ozaki N; Shinoda M; Nagamine K; Tohnai I; Ueda M; Sugiura Y
    Pain; 2005 Sep; 117(1-2):19-29. PubMed ID: 16043290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the TRPV1 endogenous agonist N-Oleoyldopamine in modulation of nociceptive signaling at the spinal cord level.
    Spicarova D; Palecek J
    J Neurophysiol; 2009 Jul; 102(1):234-43. PubMed ID: 19369364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical characterization of insulin receptor-expressing primary sensory neurons in wild-type and vanilloid type 1 transient receptor potential receptor knockout mice.
    Baiou D; Santha P; Avelino A; Charrua A; Bacskai T; Matesz K; Cruz F; Nagy I
    J Comp Neurol; 2007 Jul; 503(2):334-47. PubMed ID: 17492627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of TRPV1 loss-of-function phenotypes in TRPV1 Leu206Stop mice generated by N-ethyl-N-nitrosourea mutagenesis.
    Christoph T; Kögel B; Schiene K; Peters T; Schröder W
    Biochem Biophys Res Commun; 2018 Jun; 500(2):456-461. PubMed ID: 29660342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1.
    Christoph T; Gillen C; Mika J; Grünweller A; Schäfer MK; Schiene K; Frank R; Jostock R; Bahrenberg G; Weihe E; Erdmann VA; Kurreck J
    Neurochem Int; 2007 Jan; 50(1):281-90. PubMed ID: 17045702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin.
    Kanai Y; Hara T; Imai A
    J Pharm Pharmacol; 2006 Apr; 58(4):489-93. PubMed ID: 16597366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of TRPV1 to the bradykinin-evoked nociceptive behavior and excitation of cutaneous sensory neurons.
    Katanosaka K; Banik RK; Giron R; Higashi T; Tominaga M; Mizumura K
    Neurosci Res; 2008 Nov; 62(3):168-75. PubMed ID: 18789982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of capsaicin on VGSCs in TRPV1-/- mice.
    Cao X; Cao X; Xie H; Yang R; Lei G; Li F; Li A; Liu C; Liu L
    Brain Res; 2007 Aug; 1163():33-43. PubMed ID: 17632091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a stable cell line uniformly expressing the rat TRPV1 receptor.
    Sándor Z; Varga A; Horváth P; Nagy B; Szolcsányi J
    Cell Mol Biol Lett; 2005; 10(3):499-514. PubMed ID: 16217559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG).
    Woo DH; Jung SJ; Zhu MH; Park CK; Kim YH; Oh SB; Lee CJ
    Mol Pain; 2008 Oct; 4():42. PubMed ID: 18826653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
    Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of sensory neurogenic components in a bleomycin-induced scleroderma model using transient receptor potential vanilloid 1 receptor- and calcitonin gene-related peptide-knockout mice.
    Szabó A; Czirják L; Sándor Z; Helyes Z; László T; Elekes K; Czömpöly T; Starr A; Brain S; Szolcsányi J; Pintér E
    Arthritis Rheum; 2008 Jan; 58(1):292-301. PubMed ID: 18163477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.